Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025
   EV/Core EBITDA(x) 11.348.70

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 11.34 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202611.34
Mar20258.70

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 11.34
30.34
Mar2025 8.7 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹1,529.0 Cr -2.7% 6.3% 233.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹469,382.0 Cr 0.8% 7.3% 15.6% Stock Analytics
DIVIS LABORATORIES ₹194,375.0 Cr 1.9% 8.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,308.0 Cr 0.6% 12.6% 43.9% Stock Analytics
CIPLA ₹116,447.0 Cr 0.2% 6.3% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹102,106.0 Cr -1.8% -3.5% -3.4% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

-2.7%

6.3%

233.1%

SENSEX

0.1%

0.7%

-6.6%


You may also like the below Video Courses